Patel, D V <br/><br/>
Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  Feb 2015 
 - 499-503 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-014-2872-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--adverse effects<br/>Bone Diseases, Metabolic--drug therapy<br/>Diphosphonates--adverse effects<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Imidazoles--adverse effects<br/>Incidence<br/>Infusions, Intravenous--adverse effects<br/>Middle Aged<br/>Postmenopause<br/>Prospective Studies<br/>Scleritis--chemically induced<br/>Treatment Outcome<br/>Uveitis, Anterior--chemically induced<br/>Zoledronic Acid